$EMOR Marble Arch Research, Inc. Initiates Research

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Full Sail Scores a Billboard Nod — What's the Big Deal? Alright, Full Sail University just snagged a spot on Billboard Magazine's 2026 Top Music Business Schools list. That's no small fry, folks. This Florida institution has been carving out a niche in the music business education scene with a hands-on learning approach that hits the nail right on the head. The Recipe...

Bringing Dentistry Closer to Home Now, Whiteville's dental game just got a power-up, with Aspen Dental setting up shop in town. This isn't just another practice popping up—it's a full-on dental hub offering everything from regular cleanings to emergency tooth fixes. And let’s face it, this area's diverse population needs it. The Man Behind the Chair Guess who’s at...

Avoid Turning Halloween Fun Into a Medical Emergency Halloween should be about ghosts and ghouls, not a dreaded detour to the ER. Yet, every year, adults and kids get carried away with costumes, only to find themselves in a real-life horror show courtesy of a slip, a fall, or a carving mishap. The American Academy of Orthopaedic Surgeons (AAOS) is waving the safety flag,...

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...

Mexican Shores Turning Heads in 2026 This isn’t just another wave in tourism news; it’s a tidal shift towards Mexico’s sizzling beaches claiming some prime spots on the global travel stage. If you’ve got an eye for tourism dynamics, listen up because Mexico’s sun-soaked shores just snagged six spots among the top 20 beaches in the Americas, according to the...

Major Win for San Francisco's Parking Professionals Parking lots and garages across San Francisco might not be the first places you’d look for labor triumphs, but that’s exactly what almost 1,000 members of Teamsters Local 665 have achieved. Under a newly ratified four-year master contract, these parking pros snagged one of the richest deals the industry has seen. A...

Upcoming Data Presentations for BRIUMVI TG Therapeutics, Inc. (NASDAQ: TGTX) has unveiled an exciting schedule of data presentations that will take place at the 2024 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting. This event, focused on BRIUMVI (ublituximab-xiiy), aims to provide valuable insights for patients dealing with...

China's stock market was the center of attention as traders reflected on the significant gains following government stimulus measures back in 2024. The CSI 300 index saw its most considerable jump in over a decade, signaling a bullish shift that many were eager to ride. Stephen Jen from Eurizon SLJ Capital pointed out this moment could be just the beginning for investors...

Aethlon Medical's Hemopurifier® Gets the Green Light for Cancer Trials Aethlon Medical, Inc. (NASDAQ: AEMD), a company focused on developing solutions for difficult medical conditions, has received full ethics approval from the Medanta Institutional Ethics Committee. This approval allows them to proceed with a vital safety, feasibility, and dose-finding study of their...

EON Resources Inc. Executes Equity Sales and Executive Arrangements EON Resources Inc. (NYSE American: EONR), a prominent player in the crude petroleum and natural gas sector, recently made headlines with a series of notable unregistered equity sales. These transactions were outlined in a Form 8-K filed with the SEC, showcasing the company's proactive approach in managing...

Haemonetics Sets Date for Upcoming Financial Results Haemonetics Corporation, a leading global medical technology company, has announced that its fourth quarter and fiscal year 2025 results will be published soon. Investors and stakeholders are eagerly anticipating these results, which will offer insights into the company's performance over the past year. As a significant...